Delisting Determination, The Nasdaq Stock Market, LLC, August 5, 2025
TC BioPharm (Holdings.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove 
from listing the securities of TC BioPharm (Holdings)
effective at the opening of the trading session on August 18, 2025.
Based on review of information provided by the Company, Nasdaq Staff 
determined that the Company no longer qualified for listing on the 
Exchange pursuant to Listing Rule 5550(a)(2).The Company was 
notified of the Staff determination on January 3, 2025. 
On January 10, 2025 the Company exercised its right to appeal 
the Staff determination to the Listing Qualifications Hearings 
Panel (Panel) pursuant to Listing Rule 5815. On March 20, 2025 
the Panel reached a decision and decided to suspend the 
Company from the Exchange. The Company security was suspended 
on March 24, 2025. The Staff determination to delist 
the Company security became final on May 16, 2025.